Hikma Pharmaceuticals PLC

LSE:HIK Stock Report

Market Cap: UK£4.3b

Hikma Pharmaceuticals Future Growth

Future criteria checks 2/6

Hikma Pharmaceuticals is forecast to grow earnings and revenue by 12.2% and 4.2% per annum respectively. EPS is expected to grow by 16.1% per annum. Return on equity is forecast to be 18.8% in 3 years.

Key information

12.2%

Earnings growth rate

16.1%

EPS growth rate

Pharmaceuticals earnings growth19.7%
Revenue growth rate4.2%
Future return on equity18.8%
Analyst coverage

Good

Last updated10 Dec 2024

Recent future growth updates

Hikma Pharmaceuticals PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Aug 11
Hikma Pharmaceuticals PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Recent updates

Hikma Pharmaceuticals PLC's (LON:HIK) P/E Is On The Mark

Nov 11
Hikma Pharmaceuticals PLC's (LON:HIK) P/E Is On The Mark

Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?

Oct 24
Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?

Hikma Pharmaceuticals PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Aug 11
Hikma Pharmaceuticals PLC Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 36% Below Their Intrinsic Value Estimate

Aug 01
Hikma Pharmaceuticals PLC (LON:HIK) Shares Could Be 36% Below Their Intrinsic Value Estimate

Is Hikma Pharmaceuticals PLC (LON:HIK) Trading At A 29% Discount?

Apr 24
Is Hikma Pharmaceuticals PLC (LON:HIK) Trading At A 29% Discount?

Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?

Apr 02
Is Hikma Pharmaceuticals (LON:HIK) A Risky Investment?

Hikma Pharmaceuticals PLC's (LON:HIK) Share Price Matching Investor Opinion

Feb 25
Hikma Pharmaceuticals PLC's (LON:HIK) Share Price Matching Investor Opinion

Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?

Dec 27
Does Hikma Pharmaceuticals (LON:HIK) Have A Healthy Balance Sheet?

Earnings and Revenue Growth Forecasts

LSE:HIK - Analysts future estimates and past financials data (USD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,3445144997719
12/31/20253,2214704667249
12/31/20243,0834312575449
6/30/20243,017285379584N/A
3/31/20242,946238392596N/A
12/31/20232,875190404608N/A
9/30/20232,803168389596N/A
6/30/20232,731146373583N/A
3/31/20232,624167344557N/A
12/31/20222,517188314530N/A
9/30/20222,534267325557N/A
6/30/20222,550346335583N/A
3/31/20222,552384372611N/A
12/31/20212,553421409638N/A
9/30/20212,489444294517N/A
6/30/20212,425467179396N/A
3/31/20212,383449210430N/A
12/31/20202,341431240464N/A
9/30/20202,317472306521N/A
6/30/20202,292513372577N/A
3/31/20202,250500329525N/A
12/31/20192,207486286472N/A
9/30/20192,173424283452N/A
6/30/20192,138361279432N/A
3/31/20192,104322285431N/A
12/31/20182,070282291430N/A
9/30/20182,045-262275417N/A
6/30/20182,020-806259403N/A
3/31/20181,978-824N/A423N/A
12/31/20171,936-843N/A443N/A
9/30/20171,950-338N/A431N/A
6/30/20171,963166N/A419N/A
3/31/20171,957161N/A356N/A
12/31/20161,950155N/A293N/A
9/30/20161,782166N/A317N/A
6/30/20161,613176N/A340N/A
3/31/20161,527214N/A353N/A
12/31/20151,440252N/A366N/A
9/30/20151,450248N/A358N/A
6/30/20151,460243N/A350N/A
3/31/20151,475261N/A388N/A
12/31/20141,489278N/A425N/A
9/30/20141,477293N/A413N/A
6/30/20141,465308N/A401N/A
3/31/20141,415260N/A369N/A
12/31/20131,365212N/A337N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: HIK's forecast earnings growth (12.2% per year) is above the savings rate (2.1%).

Earnings vs Market: HIK's earnings (12.2% per year) are forecast to grow slower than the UK market (14.8% per year).

High Growth Earnings: HIK's earnings are forecast to grow, but not significantly.

Revenue vs Market: HIK's revenue (4.2% per year) is forecast to grow faster than the UK market (3.6% per year).

High Growth Revenue: HIK's revenue (4.2% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: HIK's Return on Equity is forecast to be low in 3 years time (18.8%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 00:39
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Hikma Pharmaceuticals PLC is covered by 38 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kamla SinghAlphaValue
Simon MatherBarclays
Emily FieldBarclays